But the science on this peptide is lacking (to put it lightly), so we dont know for sure
#Pharma #GLP1 #ObesityTreatment #DrugDevelopment #HealthcareInnovation #EliLilly #NovoNordisk #PharmaceuticalIndustry To view or add a comment, sign in NEW DRUG APPROVAL ALERT The FDA has approved Foundayo (orforglipron), a new once-daily oral GLP-1 for chronic weight management in adults with obesity, or adults with overweight plus at least one weight-related condition
Professional Note (for Beauty Refined clients): This formula is a game-changer in regenerative aesthetics a single vial that addresses skin, structure, and metabolism at once
How Long Does It Take to See Results From GLP-1 Therapy
These drugs work by mimicking GLP-1, a naturally occurring hormone made in the intestines
Vitamin C Deficiency: An Under-Recognized Condition in Crohns Disease